U.S. Stock News

American International Group (AIG) reported net profit margins of 11.9%, a jump from 8% a year earlier, and annual earnings growth of 50.8% dramatically outpacing its five-year average of 8.1% per year. Revenue and earnings are forecast to grow at 4.4% and 0.9% per year respectively, both tracking below broader US market trends. With margins improving and profitability standing out, the company continues to draw investor interest, especially as its valuation sits below the industry average...

If you find yourself wondering whether Fidelity National Financial is a bargain, you are in good company, and this is the right place to get clear answers. While the stock dipped 5.0% over the past month and is down 6.3% over the past year, long-term investors have still seen impressive gains of 104.6% over five years. Recent headlines have highlighted Fidelity National Financial's continued expansion in the title insurance space, along with strategic moves that have caught investors’...

In the midst of a volatile U.S. market, where concerns about AI valuations have led to fluctuations in major indices like the Dow Jones and Nasdaq, investors are closely watching earnings reports and economic indicators amid a historic government shutdown. As tech stocks face renewed scrutiny, identifying high-growth opportunities requires careful consideration of companies' adaptability to current trends and their potential for innovation in an uncertain economic landscape.

As the U.S. stock market grapples with AI valuation concerns and fluctuating index performances, investors are keenly assessing earnings reports for guidance. Amid these broader market dynamics, penny stocks—despite their somewhat outdated moniker—remain a compelling area of interest for those seeking opportunities in smaller or newer companies. By focusing on firms with solid financial foundations, investors can uncover potential value and growth prospects that larger companies may overlook.

Earlier this week, Berry Genomics announced that its Sequel II CNDx system, developed with Pacific Biosciences, received China's first Class III medical device approval for clinical-grade long-read sequencing, enabling full-scale genomic workflows for thalassemia and rare disease testing in hospitals and labs. This regulatory milestone opens up access to precision genomic diagnostics across China, an area where complex variant detection has previously been limited by short-read...

Humana (HUM) posted a softer set of headline numbers this cycle, with revenue projected to advance 7.1% per year, lagging the broader US market’s anticipated 10.4%. EPS has taken a hit, declining by 17.2% per year over the past five years, and net profit margins dipped from 1.5% to 1.3%. Yet, the outlook has flipped: forward estimates call for annual earnings growth of 26.9%, which is well ahead of the US market average of 15.8%. Meanwhile, the shares are trading below estimated fair value...

Plains All American Pipeline (PAA) posted a net profit margin of 1% for the twelve months through September 30, 2025, notably below last year’s 1.5%, as results absorbed a one-off loss of $485 million. After five years of strong profitability and a 50.6% average annual earnings growth, the trend reversed with negative earnings growth this year. Management now expects earnings to rise just 4.4% per year, which is well below the US market average of 15.8%. With revenue projected to dip slightly...

Wondering if Honest Company stock is a smart buy at this price? Let’s dive into what recent numbers and real trends are telling us about its true value. The stock has seen a notable drop lately, falling 16.9% over the past month and 51.4% year-to-date. This has sparked new questions about its growth outlook and the risks investors may be seeing. Recent headlines suggest Honest Company is exploring new product launches and expanding its retail partnerships. These moves could reshape its...

Ternium S.A. recently reported third quarter 2025 earnings, noting sales of US$3,955 million and net income of US$21 million, alongside the approval of an interim dividend of US$0.90 per ADS to be paid in November. While quarterly sales and net income declined year-over-year, the company returned to profitability over the nine-month period and maintained shareholder distributions through its dividend declaration. To better understand the implications of Ternium’s continued dividend payout...

Despite an already strong run, Victoria's Secret & Co. ( NYSE:VSCO ) shares have been powering on, with a gain of 28...

Ever wonder if Lionsgate Studios stock is a hidden gem or just another name in entertainment? Let’s break down what might make it a compelling buy or not right now. The share price has climbed 8.2% over the past week and is up 4.8% for the month, bouncing back despite a YTD slip of 14.2% and a one-year gain of 6%. Industry buzz has been stirred by recent strategic studio partnerships and growing interest in Lionsgate's expanding streaming catalog. This has fueled speculation that the...

Payoneer Global (PAYO) posted a forecasted annual earnings growth of 27.1%, outpacing the broader US market's expected 16% rise. However, revenue is projected to climb at 8.8% per year, slightly behind the US market average of 10.5%. The company’s net profit margin came in at 9.8%, lower than last year’s 11.2%, which points to tightening profitability even as earnings momentum remains strong. Over the past five years, Payoneer has averaged 74.3% annual earnings growth, but the stock now...

Middlesex Water Company recently reported third quarter 2025 earnings showing net income of US$13.96 million on sales of US$54.09 million, alongside a declared quarterly dividend increase to US$0.36 per share. This marks the company's 53rd consecutive year of raising dividends, underlining its continued emphasis on returning value to shareholders despite slightly lower earnings compared to the previous year. We'll explore how the latest dividend increase shapes Middlesex Water's broader...

ProAssurance (PRA) has swung to profitability over the past five years, reporting an annual earnings growth rate of 37.3% and showing improved profit margins in its most recent results. Forward-looking projections see earnings climbing a further 20.7% per year, notably outpacing the broader US market expectation of 16% growth, even though revenue is anticipated to edge down by 1.6% per year. With high-quality earnings and persistent profit momentum, investor focus will be on whether strong...

National Vision Holdings (EYE) has deepened its unprofitable streak, with losses compounding at a brisk 56.1% per year over the last five years and a net profit margin that remains in the red, showing no improvement in the past year. Despite the persistent losses, there is a bright spot: earnings are forecast to grow 20.57% annually, and the company is expected to reach profitability within three years, a turnaround rate that is ahead of most in the market. Revenue prospects are more muted,...

Curious if Iovance Biotherapeutics might be deeply undervalued, or if there's a catch behind the low share price? You're not alone. We're diving straight into what might be driving investor interest right now. The stock has had a rough ride, losing 9.5% in the past week and a staggering 85.1% over the last year, so there’s no denying that volatility and risk perception are front of mind for investors. Recently, clinical trial updates related to Iovance’s cancer immunotherapy platform and...

Kyndryl Holdings (KD) has turned profitable for the first time, reporting impressive annual earnings growth of 50.2% over the past five years. Looking ahead, earnings are projected to grow at 42.6% per year, significantly above the US market’s 15.8% average, while revenue is expected to rise at a more modest 3.5% per year. The company’s net profit margin has improved, making profitability the highlight of this latest release. See our full analysis for Kyndryl Holdings. Now, let’s see how...

MNTN (MNTN) remains in the red, with net losses having deepened at a pace of 14.8% per year over the last five years and no sign yet of a positive net profit margin. That said, there is a bold turnaround forecast: earnings are projected to grow at a steep 90.92% annually, with a shift into profitability expected within three years. With revenue growth expectations of 18% per year outpacing the wider US market, the latest results put all eyes on whether strong forward momentum will finally...

Zimmer Biomet Holdings (ZBH) posted a net profit margin of 10.5%, down from 13.3% a year ago, marking a drop in profitability as the company absorbed a $304.6 million one-off loss over the last twelve months. While the average annual earnings growth stood at a solid 26.4% over the past five years, recent performance took a hit with negative earnings growth this year, making direct comparisons to historical trends less meaningful. Looking forward, earnings are forecast to increase by 14.2% per...

OppFi (OPFI) just raised its revenue expectations for 2025 and completed a notable share repurchase. These are two clear signals that management is confident about the company’s direction and prospects next year. See our latest analysis for OppFi. After the upbeat revenue outlook and completion of its buyback, OppFi’s positive momentum stands out. The 1-year total shareholder return sits at 89.5%, and its 3-year total return is an impressive 454%. These strong numbers have caught investor...

Curious if PACCAR stock is a good deal right now? Let’s break down whether there’s value hidden beneath the hood. PACCAR’s share price has moved up 2.6% in the last week and 2.3% over the past month, even though it remains down 2.6% year-to-date and 9.6% over the past year. Long-term holders have still seen strong gains of over 100% in five years. Recent news around PACCAR includes supply chain updates and continued investments in electric vehicle development, both drawing attention from...

Ever wondered if Entegris is a hidden gem or if its recent price can be justified? You are not alone. Let’s explore whether it is truly undervalued right now. The stock has been on a bit of a rollercoaster, dropping 6.4% over the last week and losing 11.7% in the past month. This has led to a year-to-date decline of 9.0% and a 15.4% dip over the last year. However, it still boasts a three-year return of 38.2%. Recent news has put Entegris in the spotlight, with industry-wide concerns about...

Ichor Holdings (ICHR) is making headlines after Philip Barros stepped in as CEO, following Jeffrey Andreson’s resignation. This executive transition comes at a time when the company delivered mixed third-quarter results, sparking debate among investors about its next strategic moves. See our latest analysis for Ichor Holdings. Following the CEO transition and mixed earnings, Ichor Holdings’ share price has been on a rollercoaster, surging over 6% in a day after earnings but still lagging...

LTC Properties (LTC) reported net profit margins of 38.7% for the recent period, down from 47.6% a year ago, reflecting a notable decline in profitability. Over the past five years, the company’s earnings have grown 5.9% annually and are projected to increase by 6.47% per year going forward, which is well below the broader US market’s 16% forecasted annual growth. Investors may note that while LTC’s profit outlook trails the market, revenue is expected to climb 32.8% per year, which is...